FTC Wants To Extend Actavis To Authorized Generics Deals
The Federal Trade Commission on Wednesday urged a New Jersey federal judge overseeing private antitrust litigation targeting an authorized generics deal between Wyeth LLC and Teva Pharmaceuticals USA Inc. to apply...To view the full article, register now.
Already a subscriber? Click here to view full article